Stable Isotope Labeling of Sphingolipids-Uniformly labeled
13 C-palmitate was mixed with fatty acid-free bovine serum albumin (BSA) at a 1:1 molar ratio to make a 1 mM solution 1 which was diluted to 0.1 mM with complete cell culture medium and filter sterilized just before use. The [U-13 C]-palmitate/BSA was added to cells at the same time as the KLA or vehicle, incubated for up to 24 h, then the cells were extracted for lipid analysis as described previously (1, 2) . To quantitate the three categories of SLs labeled with [U-
13 C]-palmitate (i.e., in the sphingoid base backbone alone-which we designate "Base-labeled"-in the fatty acid only-"Fatty acidlabeled"-and both the sphingoid base and fatty acid-"Dual-labeled"), the additional multiple reaction monitoring (MRM) pairs were added: the [ The MRM extracted ion chromatogram peak areas of all four SL isotopomers were integrated (Analyst 1.4), converted to picomoles using the peak areas of the internal standards, and normalized to the micrograms of DNA in the sample, except where otherwise noted.
Generation of RAW264.7 cells stably expressing GFP-LC3-LC3A
cDNA was obtained from Origene. To generate N-terminal GFP-tagged LC3, the LC3A gene was amplified using the following gene-specific primers: 5'-ATGCCCTCAGACCGGCCTTT-3' and 5'-GAAGCCGAAGGTTTCCTGGGAGG-3'. The PCR fragment corresponding to the coding sequence of LC3A was then cloned into pEGFP-C2/SmaI (Clonetech, Mountain View, CA) resulting pEGFP-C2-LC3A. Sequencing was used to confirm the fidelity of the construct.
RAW264.7 cells stably expressing green fluorescent protein (GFP)-tagged LC3 were generated by transfection with pEFGP-C2-LC3A. Transfection was performed in 100-mm dishes (3.0 x 10 6 cells/dish) with 6 !g plasmid DNA/plate with GeneJuice® (Novagen; EMD Biosciences, San Diego, CA) according to the manufacturer's protocol. Following 48 h of exposure, cells were washed with PBS and selected in media containing 300 !g/mL of G418 (Sigma-Aldrich) for 14 days. The media was changed every other day. After two weeks, selected G418-resistant colonies were cloned by two rounds of limiting dilution in a 96 well plate order to establish fluorescent colonies originating from a single cell. In order to confirm localization and expression of the LC3, GFP-LC3-transfected RAW264.7 cells were cultured on 12 mm cover slips (VWR; West Chester, PA). Following exposure to Kdo 2 -Lipid A (Avanti Polar Lipids; Alabaster, AL) for 24 h, cells were fixed in 4% formaldehyde and analyzed by fluorescence confocal microscopy.
Immunohistochemical Analysis of the ER and Golgi-For visualization of the ER and Golgi, fixed cells were permeabilized with 0.2% Triton X-100 for 5 min, blocked in 3% BSA, 2% serum in PBS for 2 h, and subjected to indirect immunofluorescence staining. Cells were incubated overnight at 4 °C with anti-BiP (1:500) for visualization of the ER or anti-GM130 (1:500) for visualization of the Golgi diluted in 0.1% BSA in PBS. The cells were washed three times with PBS and incubated with the Alexa Fluor-conjugated secondary antibody (1:200) diluted in 0.1% BSA in PBS for 3 h at room temperature prior to nucleic acid staining.
Immunohistochemical Analysis of Ceramide Localization-Cer staining was performed through the adaptation of (26). Briefly, for surface Cer staining, the non-specific binding sites of fixed cells were saturated for 2 h at room temperature with 3% BSA, 2% serum in PBS followed by overnight incubation at 4°C with anti-ceramide (1:50) diluted in 0.1% BSA. In order to visualize intracellular ceramide, the staining protocol was continued with a second fixation with 4% formaldehyde for 20 min at room temperature. The cells were then washed twice with PBS and permeabilized with 0.2% Triton X-100 for 5 min. Non-specific intracellular binding sites were blocked with 3% BSA, 2% serum in PBS for 45 min followed by overnight incubation at 4°C with anti-Cer Ab (1:50) diluted in 0.1% BSA. The cells were then washed three times and incubated with the Alexa Fluor-conjugated secondary antibody (1:200) diluted in 0.1% BSA for 3 h at room temperature prior to nucleic acid staining.
Immunohistochemical Analysis of SPT and 3KSR Localization-Serine palmitoyltransferase (SPT) staining was performed as previously described (35). For 3-ketosphinganine reductase (3KSR) staining, fixed cells were permeabilized with 0.2% Triton X-100 for 5 min, blocked in 10% FBS in PBS for 1 h, and subjected to indirect immunofluorescence staining. Cells were incubated overnight at 4 °C with anti-HA-tag (1:800) diluted in 10% FBS in PBS. The cells were washed three times with 10% FBS and incubated with the Alexa Fluor-conjugated secondary antibody (1:200) diluted in 10% FBS for 2 h at room temperature.
Measurement of Cell Diameter and Area-RAW264.7 cells were cultured on glass coverslips (VWR, Inc. West Chester, PA) in a 24-well plate. Following treatment, cells were fixed with 4% formaldehyde in PBS at room temperature for 15 min. Fixed cells were rinsed in PBS and mounted in Fluoromount G (Southern Biotechnology Associates, Inc., Birmingham, AL) prior to observation under a Zeiss LSM 510 inverted laser scanning confocal microscope (Heidelberg, Germany). Bright field images were collected with the resident Zeiss confocal microscope software and cellular diameter measured using ImageJ version 1.41a (National Institute of Health). The surface area was calculated using the measured diameter. 
Analysis of Autophagy in CHO-LYB and CHO-LYB-LCB1 Cells-CHO-LYB and CHO-LYB-LCB1 cells were obtained from Ken Hanada and verified to have the phenotype of being defective in de novo SL biosynthesis due to mutation of SPT1 (CHO-LYB) (3). This pathway is restored in the CHO-LYB-LCB1 cell line by stable transfection with wild-type SPT1 (3). In order to monitor autophagy, CHO-LYB and CHO-LYB-LCB1 cells were transfected with GFP-

